Free Trial

Owens & Minor (OMI) Competitors

Owens & Minor logo
$6.91 -0.39 (-5.33%)
As of 03:32 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

OMI vs. MCK, COR, CAH, HSIC, PDCO, APLS, BCRX, DNLI, VCEL, and ARDT

Should you be buying Owens & Minor stock or one of its competitors? The main competitors of Owens & Minor include McKesson (MCK), Cencora (COR), Cardinal Health (CAH), Henry Schein (HSIC), Patterson Companies (PDCO), Apellis Pharmaceuticals (APLS), BioCryst Pharmaceuticals (BCRX), Denali Therapeutics (DNLI), Vericel (VCEL), and Ardent Health Partners (ARDT). These companies are all part of the "medical" sector.

Owens & Minor vs.

McKesson (NYSE:MCK) and Owens & Minor (NYSE:OMI) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, valuation, earnings, risk, dividends, institutional ownership, media sentiment and profitability.

McKesson has a beta of 0.53, indicating that its stock price is 47% less volatile than the S&P 500. Comparatively, Owens & Minor has a beta of 1.38, indicating that its stock price is 38% more volatile than the S&P 500.

In the previous week, McKesson had 27 more articles in the media than Owens & Minor. MarketBeat recorded 34 mentions for McKesson and 7 mentions for Owens & Minor. McKesson's average media sentiment score of 1.51 beat Owens & Minor's score of 1.09 indicating that McKesson is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
McKesson
31 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Owens & Minor
5 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

McKesson presently has a consensus target price of $686.69, indicating a potential downside of 4.37%. Owens & Minor has a consensus target price of $12.50, indicating a potential upside of 78.95%. Given Owens & Minor's higher probable upside, analysts plainly believe Owens & Minor is more favorable than McKesson.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
McKesson
0 Sell rating(s)
3 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.87
Owens & Minor
2 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.00

McKesson received 722 more outperform votes than Owens & Minor when rated by MarketBeat users. Likewise, 74.28% of users gave McKesson an outperform vote while only 48.04% of users gave Owens & Minor an outperform vote.

CompanyUnderperformOutperform
McKessonOutperform Votes
979
74.28%
Underperform Votes
339
25.72%
Owens & MinorOutperform Votes
257
48.04%
Underperform Votes
278
51.96%

McKesson has a net margin of 0.82% compared to Owens & Minor's net margin of -0.46%. Owens & Minor's return on equity of 14.60% beat McKesson's return on equity.

Company Net Margins Return on Equity Return on Assets
McKesson0.82% -181.26% 5.34%
Owens & Minor -0.46%14.60%2.51%

McKesson has higher revenue and earnings than Owens & Minor. Owens & Minor is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
McKesson$359.05B0.25$3.00B$25.8327.80
Owens & Minor$10.72B0.05-$41.30M-$4.75-1.47

85.1% of McKesson shares are held by institutional investors. Comparatively, 98.0% of Owens & Minor shares are held by institutional investors. 0.1% of McKesson shares are held by company insiders. Comparatively, 3.7% of Owens & Minor shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

McKesson beats Owens & Minor on 14 of the 19 factors compared between the two stocks.

Get Owens & Minor News Delivered to You Automatically

Sign up to receive the latest news and ratings for OMI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OMI vs. The Competition

MetricOwens & MinorMedical & hospital equipment IndustryMedical SectorNYSE Exchange
Market Cap$539.63M$7.96B$5.40B$19.61B
Dividend YieldN/A1.98%5.22%3.84%
P/E Ratio-10.7521.0626.7434.79
Price / Sales0.051.16394.9335.55
Price / Cash1.2510.7638.2517.51
Price / Book0.582.166.874.75
Net Income-$41.30M$259.21M$3.23B$1.02B
7 Day Performance-1.06%0.11%5.01%0.00%
1 Month Performance7.30%5.10%12.82%11.34%
1 Year Performance-60.49%-6.58%17.63%4.68%

Owens & Minor Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OMI
Owens & Minor
4.8139 of 5 stars
$6.91
-5.3%
$12.50
+80.9%
-59.4%$533.91M$10.72B-10.6322,500Positive News
Gap Down
MCK
McKesson
4.4083 of 5 stars
$686.92
-0.9%
$686.69
0.0%
+27.5%$86.09B$344.58B31.4575,000Positive News
Analyst Downgrade
High Trading Volume
COR
Cencora
4.5672 of 5 stars
$278.35
-1.6%
$301.18
+8.2%
+32.4%$53.98B$638.56M39.5942,000Positive News
High Trading Volume
CAH
Cardinal Health
4.6762 of 5 stars
$148.50
+0.2%
$146.43
-1.4%
+57.1%$35.44B$222.29B27.7146,500Positive News
HSIC
Henry Schein
2.7179 of 5 stars
$70.47
+2.7%
$79.30
+12.5%
-0.5%$8.58B$12.67B29.0022,000Positive News
PDCO
Patterson Companies
1.4097 of 5 stars
$31.33
flat
$26.57
-15.2%
N/A$2.77B$6.51B18.327,700News Coverage
APLS
Apellis Pharmaceuticals
4.0974 of 5 stars
$17.52
+1.3%
$41.37
+136.1%
-57.2%$2.20B$781.37M-8.63770
BCRX
BioCryst Pharmaceuticals
4.636 of 5 stars
$10.34
+3.7%
$16.56
+60.1%
+68.5%$2.16B$503.49M-16.95530Positive News
DNLI
Denali Therapeutics
4.4646 of 5 stars
$14.80
+3.0%
$33.79
+128.3%
-29.0%$2.15B$330.53M-5.36430Analyst Forecast
VCEL
Vericel
2.5802 of 5 stars
$42.65
+2.2%
$60.86
+42.7%
-14.9%$2.14B$238.54M710.95300Positive News
ARDT
Ardent Health Partners
3.2244 of 5 stars
$14.85
+2.3%
$20.75
+39.7%
N/A$2.12B$6.02B9.1124,200Analyst Forecast

Related Companies and Tools


This page (NYSE:OMI) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners